As of now, the FDA does not approve the use of the AOD 9604 peptide for weight loss, despite some research suggesting that it may stimulate the burning of fat
Data are lacking from long-term studies to assess whether oral treatment is effective when doses are administered less frequently than daily
However, this frequency declines as they reach their objectives
Strong response suggests maintaining current dosing
Additionally, Crohns disease, celiac disease, and other intestinal issues increase the odds of developing a B12 deficiency
Why combination research differs from single-compound studies Combination studies require a different research design than single-compound studies, since researchers need to account for potential interactions between two active mechanisms rather than measuring a single variable in isolation